Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on September 30, 2026

Sep. 30, 2026

DiFusion Activates Operating Board to Scale Therapeutic Biomaterials Platform

Indeterminate GlobeNewswire

Sep. 30, 2026

Asure Software Accelerates Alabama Investment with U of Alabama HR Management Conference Sponsorship Followed by October 23 Gardendale Open House

Indeterminate GlobeNewswire

Sep. 30, 2026

Rocket Doctor AI to Present at the 153rd National Investment Banking Association (NIBA) Conference in Florida

Indeterminate GlobeNewswire

Sep. 30, 2026

Firefly Aerospace Signs Starcloud as Commercial Customer, Demonstrating Data Center Capabilities Around the Moon

Indeterminate GlobeNewswire

Sep. 30, 2026

Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer Published in Nature Medicine

Indeterminate GlobeNewswire

Sep. 30, 2026

Esperion Therapeutics Offers Short-Term Option for Diuretic Management Before Escalation to IV for Patients With Heart Failure

Indeterminate GlobeNewswire

Sep. 30, 2026

AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450

Indeterminate GlobeNewswire

Sep. 30, 2026

Rezera Announces Phase 1 Results for Trabzanoflast, which was Generally Well Tolerated and Demonstrated High Central Nervous System Exposure (CNS)

Indeterminate GlobeNewswire

Sep. 30, 2026

ROC Advances to Global Leader for Age Estimation Accuracy in NIST FATE AEV

Indeterminate GlobeNewswire

Sep. 30, 2026

Celcuity Announces That REVTORPYK™ (gedatolisib) Is Now Commercially Available In The United States

Indeterminate GlobeNewswire

Sep. 30, 2026

Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis

Indeterminate GlobeNewswire

Sep. 30, 2026

Immutep Receives ~A$0.86 Million R&D Tax Incentive

Indeterminate GlobeNewswire

Sep. 30, 2026

Parabolic Announces $9.3 Million in Annualized Cost Savings from ConnectAndSell Integration and Business Unit Realignment

Indeterminate GlobeNewswire

Sep. 30, 2026

Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences

Indeterminate GlobeNewswire

Sep. 30, 2026

Cycurion Discusses Record Contract Win, Public Safety Expansion and Growth Strategy in New Interview

Indeterminate GlobeNewswire

Sep. 30, 2026

Federal Court Rules in Favor of Genius Group, Denying All Motions to Dismiss in RICO Lawsuit

Indeterminate GlobeNewswire

Sep. 30, 2026

MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy

Indeterminate GlobeNewswire

Sep. 30, 2026

CURE ALZHEIMER’S FUND AWARDS $6.4 MILLION TO CARDINAL FAMILY SCHOLARS ADVANCING ALZHEIMER’S RESEARCH

Indeterminate GlobeNewswire

Sep. 30, 2026

Centerra Gold Provides Notice of Third Quarter 2026 Results and Conference Call

Indeterminate GlobeNewswire

Sep. 30, 2026

AGM Group Advances AI Inference Strategy, Storage Integration and Server Deliveries

Indeterminate GlobeNewswire